Corcept Therapeutics Incorporated (CORT) ROE US GAAP (year values) |
|||||||||
2020 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
ROE, % | ? | 20.3% | 20.3% | 29.9% | 20.2% | 20.9% | 22.1% | ||
Changes by years, y/y, % | -5pp | 0pp | +10pp | -10pp | +1pp | -5.2% |
Corcept Therapeutics Incorporated. ROE, %
Corcept Therapeutics Incorporated. ROE, changes, pp
Corcept Therapeutics Incorporated (CORT) ROE US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
ROE, % | ? | 19.8% | 20.9% | 21.5% | 21.1% | 22.1% | 22.1% | |
Changes by years, y/y, % | -5pp | +1pp | +4pp | -1pp | +2pp | |||
Changes by quarters, q/q, % | -3pp | +1pp | +1pp | 0pp | +1pp |